Immunohistochemical Validation of Multiple Phospho-specific Epitopes for Estrogen Receptor Alpha (ERalpha) in Tissue Microarrays of ERalpha Positive Human Breast Carcinomas

Overview

Journal Breast Cancer Res Treat

Specialty Oncology

Date 2008 Dec 24

PMID 19104930

Citations 21

Authors

George P Skliris

Brian G Rowan

Mariam Al-Dhaheri

Christopher Williams

Sandy Troup

Sanela Begic

Michelle Parisien

Peter H Watson

Leigh C Murphy

Affiliations

Soon will be listed here.

Abstract

Estrogen receptor alpha (ERalpha) activity is regulated by phosphorylation at several sites. Recently several antibodies specific for individual phosphorylated sites within ERalpha have became available. Such antibodies potentially provide invaluable tools to gain insight into the relevance in vivo of phosphorylated ERalpha in human breast tumors. However, validation of these antibodies for immunohistochemistry in particular is necessary in the first instance. In this study we have investigated the usefulness of several antibodies generated to specific phosphorylated sites within ERalpha for immunohistochemistry of formalin-fixed, paraffin-embedded human breast cancer biopsy samples. As well, these data demonstrate for the first time, the detection of multiple phosphorylated ERalpha forms in breast cancer (P-S104/106-ERalpha, P-S118-ERalpha, P-S167-ERalpha, P-S282-ERalpha, P-S294-ERalpha, P-T311-ERalpha, and P-S559-ERalpha) suggesting the possibility that profiling of phosphorylated ERalpha isoforms might be useful in selecting subgroups of breast cancer patients that would benefit from endocrine therapy.

Citing Articles

Overlap of Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Matched Tissues for Proteomics and Phosphoproteomics.

Humphries E, Hains P, Robinson P ACS Omega. 2025; 10(7):6891-6900.

PMID: 40028131 PMC: 11865994. DOI: 10.1021/acsomega.4c09289.

Guidelines on antibody use in physiology research.

Brooks H, de Castro Bras L, Brunt K, Sylvester M, Parvatiyar M, Sirish P Am J Physiol Renal Physiol. 2024; 326(3):F511-F533.

PMID: 38234298 PMC: 11208033. DOI: 10.1152/ajprenal.00347.2023.

Autophagy Analysis: A Step-by-Step Simple Practical Guide for Immunofluorescence and Western Blotting.

Murthy M, Khandayataray P, Samal D, Pattanayak R, Mohanty C Methods Mol Biol. 2023; 2879:1-22.

PMID: 38095835 DOI: 10.1007/7651_2023_508.

Immunofluorescence Staining of Paraffin Sections Step by Step.

Zaqout S, Becker L, Kaindl A Front Neuroanat. 2020; 14:582218.

PMID: 33240048 PMC: 7680859. DOI: 10.3389/fnana.2020.582218.

Fibronectin rescues estrogen receptor α from lysosomal degradation in breast cancer cells.

Sampayo R, Toscani A, Rubashkin M, Thi K, Masullo L, Violi I J Cell Biol. 2018; 217(8):2777-2798.

PMID: 29980625 PMC: 6080927. DOI: 10.1083/jcb.201703037.

References

Weitsman G, Li L, Skliris G, Davie J, Ung K, Niu Y . Estrogen receptor-alpha phosphorylated at Ser118 is present at the promoters of estrogen-regulated genes and is not altered due to HER-2 overexpression. Cancer Res. 2006; 66(20):10162-70. DOI: 10.1158/0008-5472.CAN-05-4111. View

Murphy L, Niu Y, Snell L, Watson P . Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen. Clin Cancer Res. 2004; 10(17):5902-6. DOI: 10.1158/1078-0432.CCR-04-0191. View

Arnold S, Vorojeikina D, Notides A . Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J Biol Chem. 1995; 270(50):30205-12. DOI: 10.1074/jbc.270.50.30205. View

Emberley E, Niu Y, Curtis L, Troup S, Mandal S, Myers J . The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer. Cancer Res. 2005; 65(13):5696-702. DOI: 10.1158/0008-5472.CAN-04-3927. View

Lee H, Bai W . Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation. Mol Cell Biol. 2002; 22(16):5835-45. PMC: 133965. DOI: 10.1128/MCB.22.16.5835-5845.2002. View

Weigel N, Moore N . Steroid receptor phosphorylation: a key modulator of multiple receptor functions. Mol Endocrinol. 2007; 21(10):2311-9. DOI: 10.1210/me.2007-0101. View

Yang C, Xin H, Kelley J, Spencer A, Brautigan D, Paschal B . Ligand binding to the androgen receptor induces conformational changes that regulate phosphatase interactions. Mol Cell Biol. 2007; 27(9):3390-404. PMC: 1899975. DOI: 10.1128/MCB.02411-06. View

Murphy L, Cherlet T, Adeyinka A, Niu Y, Snell L, Watson P . Phospho-serine-118 estrogen receptor-alpha detection in human breast tumors in vivo. Clin Cancer Res. 2004; 10(4):1354-9. DOI: 10.1158/1078-0432.ccr-03-0112. View

Zoubir M, Mathieu M, Mazouni C, Liedtke C, Corley L, Geha S . Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacy. Ann Oncol. 2008; 19(8):1402-1406. DOI: 10.1093/annonc/mdn151. View

10.

Murphy L, Weitsman G, Skliris G, Teh E, Li L, Peng B . Potential role of estrogen receptor alpha (ERalpha) phosphorylated at Serine118 in human breast cancer in vivo. J Steroid Biochem Mol Biol. 2006; 102(1-5):139-46. DOI: 10.1016/j.jsbmb.2006.09.021. View

11.

Bergqvist J, Elmberger G, Ohd J, Linderholm B, Bjohle J, Hellborg H . Activated ERK1/2 and phosphorylated oestrogen receptor alpha are associated with improved breast cancer survival in women treated with tamoxifen. Eur J Cancer. 2006; 42(8):1104-12. DOI: 10.1016/j.ejca.2006.01.028. View

12.

Skliris G, Leygue E, Curtis-Snell L, Watson P, Murphy L . Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Br J Cancer. 2006; 95(5):616-26. PMC: 2360679. DOI: 10.1038/sj.bjc.6603295. View

13.

Sarwar N, Kim J, Jiang J, Peston D, Sinnett H, Madden P . Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression. Endocr Relat Cancer. 2006; 13(3):851-61. DOI: 10.1677/erc.1.01123. View

14.

Yamashita H, Nishio M, Kobayashi S, Ando Y, Sugiura H, Zhang Z . Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer. Breast Cancer Res. 2005; 7(5):R753-64. PMC: 1242143. DOI: 10.1186/bcr1285. View

15.

Barnes R, Parisien M, Murphy L, Watson P . Influence of evolution in tumor biobanking on the interpretation of translational research. Cancer Epidemiol Biomarkers Prev. 2008; 17(12):3344-50. DOI: 10.1158/1055-9965.EPI-08-0622. View

16.

Williams C, Basu A, El-Gharbawy A, Carrier L, Smith C, Rowan B . Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2. BMC Biochem. 2010; 10:36. PMC: 2811108. DOI: 10.1186/1471-2091-10-36. View

17.

Al-Dhaheri M, Rowan B . Application of phosphorylation site-specific antibodies to measure nuclear receptor signaling: characterization of novel phosphoantibodies for estrogen receptor alpha. Nucl Recept Signal. 2006; 4:e007. PMC: 1472668. DOI: 10.1621/nrs.04007. View

18.

Watson P, Snell L, Parisien M . The NCIC-Manitoba Breast Tumor Bank: a resource for applied cancer research. CMAJ. 1996; 155(3):281-3. PMC: 1487994. View

19.

Chen D, Pace P, Coombes R, Ali S . Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization. Mol Cell Biol. 1999; 19(2):1002-15. PMC: 116031. DOI: 10.1128/MCB.19.2.1002. View

20.

Snell L, Watson P . Breast tissue banking: collection, handling, storage, and release of tissue for breast cancer research. Methods Mol Med. 2006; 120:3-24. View